Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
A New Framework Establishes 'The Hallmarks of Skeletal Muscle Health'
EIN Presswire
An international consortium of experts outlines a unifying conceptual framework to transform precision diagnostics, therapeutics, and healthy aging strategies TORONTO, CANADA, August 20, 2026 /EINPresswire.com/ -- Today, an international team of...
UNCF Announces Historic $12 Million Gift from The James and Judith K. Dimon Foundation to Strengthen HBCU Endowments and Expand Pathways in Healthcare and Education
GlobeNewswire, Inc.
Washington, DC, Aug. 20, 2026 (GLOBE NEWSWIRE) -- UNCF announced The Dimon Fund to Advance Economic Opportunity, a historic $12 million gift from The James and Judith K. Dimon Foundation to strengthen the long-term sustainability of historically...
Zealand Pharma - Transactions related to share buy-back program (week 33, 2026)
GlobeNewswire, Inc.
Company announcement No. 40 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 33, 2026) Copenhagen, Denmark, August 17, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a...
Zealand Pharma Announces Financial Results for the First Half of 2026
GlobeNewswire, Inc.
Company announcement – No. 39 / 2026 Zealand Pharma Announces Financial Results for the First Half of 2026 A landmark first half defined by key milestones delivered for leading obesity assets, and a continued momentum building across all fronts of...
Ascendis Pharma Reports Second Quarter 2026 Financial Results
GlobeNewswire, Inc.
– Q2 2026 product revenue of €315 million (+105% Y/Y), comprising €252 million for YORVIPATH®, €55 million for SKYTROFA®, and €8 million for YUVIWEL® – Through July 31, more than 220 unique YUVIWEL patient enrollments in the U.S. – Substantial...
CIP and Thylander start construction of energy-integrated data centre in Denmark backed by PensionDanmark
GlobeNewswire, Inc.
One of the first major data centres to be wholly owned and operated by Danish companies is now being established in Esbjerg, in southern Denmark.
Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide
GlobeNewswire, Inc.
Company announcement – No. 38 / 2026 Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide Zealand Pharma will receive USD 100 million for the sale of its...
Expanded Access Case Report of SNIPR001, an Engineered CRISPR Medicine, in Rare Intracellular E. coli Disease Published in Clinical Infectious Diseases
GlobeNewswire, Inc.
COPENHAGEN, Denmark, Aug. 12, 2026 (GLOBE NEWSWIRE) -- SNIPR today announced the publication of a peer-reviewed expanded access case report in Clinical Infectious Diseases https://doi.org/10.1093/cid/ciag446 describing the use of SNIPR001 in a...
Zealand Pharma - Transactions related to share buy-back program (week 32, 2026)
GlobeNewswire, Inc.
Company announcement No. 37 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 32, 2026) Copenhagen, Denmark, August 10, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a...
Bioengineered blood vessel for Coronary Bypass Sustains 18-Month Patency — With a Full Year without Blood Thinners
GlobeNewswire, Inc.
ST. PAUL, Minn., Aug. 21, 2026 (GLOBE NEWSWIRE) -- Vascudyne, Inc. today announced the publication in Nature Communications of results supporting an off-the-shelf bioengineered blood vessel for coronary artery bypass grafting (CABG)—an option that...
Bavarian Nordic Reports Strong First Half 2026 Results
GlobeNewswire, Inc.
COPENHAGEN, Denmark, August 21, 2026 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress for the second quarter and first half of 2026 and released its financial calendar for 2027. Financial...
Rinn Pharma & Biopharma Expands European Research Collaboration Through NordicPharmaTrain Partnership
EIN Presswire
Rinn Pharma & Biopharma expanding collaborative research and training across the Nordic and European innovation landscape.
Zealand Pharma conference call on August 13 at 2pm CEST (8am ET) to present second quarter 2026 financial results
GlobeNewswire, Inc.
Press Release – No. 14 / 2026 Zealand Pharma conference call on August 13 at 2pm CEST (8am ET) to present second quarter 2026 financial results Copenhagen, Denmark, August 6, 2026 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a...
Lexicon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Clinical Updates
GlobeNewswire, Inc.
Enrollment complete in Phase 3 SONATA-HCM study; top-line data expected Q1 2027 NDA resubmission activities for ZYNQUISTA® in type 1 diabetes nearing completion Phase 1 clinical development of LX9851 ongoing by Novo Nordisk Conference call and...
Annexon Reports First U.S. and European Patient Cohort of GBS FORWARD Study Demonstrated Rapid, Positive Clinical Responses in All Tanruprubart Treated Patients Within One Week
GlobeNewswire, Inc.
Early Outcomes Reinforce the Consistency and Reproducibility of Tanruprubart Treatment Effect Previously Demonstrated in Phase 3 and Real-World Evidence Studies Potential to Become the First Approved Targeted Therapy to Treat GBS Worldwide,...
86th Training Division WAREX-Regional Medic 2026 showcases Fort McCoy’s ability to support large-scale, multinational readiness training
DVIDS - Georgia
Thousands of U.S. Army Reserve Soldiers, along with joint, Total Force and multinational partners, converged on Fort McCoy during July and August for the 86th Training Division’s Warrior Exercise (WAREX)-Regional Medic 2026 — a large-scale...
Randomized U.S. Trial Finds Autonomous System Improves Precision of Hospital Oxygen Therapy
GlobeNewswire, Inc.
Copenhagen, Denmark, Aug. 03, 2026 (GLOBE NEWSWIRE) -- — O2matic ApS today announced results from a randomized, multicenter U.S. clinical trial showing that hospitalized patients receiving autonomous oxygen titration with the O2matic PRO 100 spent...
H1 Partners with Novo Nordisk to Scale AI-Driven Clinical Development
GlobeNewswire, Inc.
NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- H1 today announced a new partnership with Novo Nordisk to improve clinical development in the age of AI. The partnership aims to develop proprietary AI-ready data and AI-powered clinical development...
NRG Therapeutics Announces the Appointment of Claus Sundgreen M.D. as Chief Medical Officer
GlobeNewswire, Inc.
STEVENAGE, United Kingdom, Aug. 03, 2026 (GLOBE NEWSWIRE) -- NRG Therapeutics Ltd. (“NRG”), a clinical stage neuroscience company developing novel disease-modifying therapeutics that rectify mitochondrial dysfunction in neurodegenerative diseases,...
Evaxion announces business update and second quarter 2026 financial results
GlobeNewswire, Inc.
COPENHAGEN, Denmark, August 20, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, provides business update and announces second quarter 2026...
Sign up for:
Healthcare Times Denmark
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.